Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep71: Learning from AI: Lessons for Digital Therapeutic Pioneers

34:47
 
Share
 

Manage episode 372830575 series 2857558
Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode, we hear from Sean Khozin, Senior Partner at the investment firm Braven Partners. He focuses on advancing in innovations at the intersection of biology, technology and AI. Sean was previously the CEO of CancerLinQ and the Global Head of Data Strategy and Data Science at Johnson & Johnson. He had a successful tenure in the US federal government as the associate director of FDA’s Oncology Center of Excellence and the founding executive director of FDA INFORMED, a data science and technology incubator he established under special authorities from the US department of health and human services.

Topics include:

  • How are Braven Partners incubating and supporting minimally viable ecosystems of companies that can make a difference?
  • What are the goals of the Alliance for Artificial Intelligence in Healthcare?
  • How can digital therapeutics developers ensure effective reimbursement for their products in the healthcare industry?
  • How is the ethos of AI in healthcare speaking to a culture that is focused on safety without compromising innovation?
  • How do we demystify new tools and technologies such as AI?
  • How does the FDA think about regulating AI?
  • What can digital therapeutic manufacturers companies, entrepreneurs and trailblazers learn from the Alliance for Artificial Intelligence in Healthcare (AAIH)?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

103 episodes

Artwork
iconShare
 
Manage episode 372830575 series 2857558
Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode, we hear from Sean Khozin, Senior Partner at the investment firm Braven Partners. He focuses on advancing in innovations at the intersection of biology, technology and AI. Sean was previously the CEO of CancerLinQ and the Global Head of Data Strategy and Data Science at Johnson & Johnson. He had a successful tenure in the US federal government as the associate director of FDA’s Oncology Center of Excellence and the founding executive director of FDA INFORMED, a data science and technology incubator he established under special authorities from the US department of health and human services.

Topics include:

  • How are Braven Partners incubating and supporting minimally viable ecosystems of companies that can make a difference?
  • What are the goals of the Alliance for Artificial Intelligence in Healthcare?
  • How can digital therapeutics developers ensure effective reimbursement for their products in the healthcare industry?
  • How is the ethos of AI in healthcare speaking to a culture that is focused on safety without compromising innovation?
  • How do we demystify new tools and technologies such as AI?
  • How does the FDA think about regulating AI?
  • What can digital therapeutic manufacturers companies, entrepreneurs and trailblazers learn from the Alliance for Artificial Intelligence in Healthcare (AAIH)?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

103 episodes

Semua episod

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play